• LAST PRICE
    6.1550
  • TODAY'S CHANGE (%)
    Trending Down-0.4350 (-6.6009%)
  • Bid / Lots
    6.1500/ 149
  • Ask / Lots
    6.1600/ 28
  • Open / Previous Close
    6.5100 / 6.5900
  • Day Range
    Low 6.1500
    High 6.5800
  • 52 Week Range
    Low 4.9700
    High 15.7400
  • Volume
    3,417,762
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 6.59
TimeVolumeRXRX
09:32 ET432286.58
09:34 ET462176.53
09:36 ET94276.515
09:38 ET461036.505
09:39 ET8558726.4
09:41 ET2718246.385
09:43 ET1181536.45
09:45 ET271446.445
09:48 ET279316.46
09:50 ET145166.475
09:52 ET95866.445
09:54 ET164216.41
09:56 ET205976.43
09:57 ET269516.43
09:59 ET161526.424
10:01 ET353056.48
10:03 ET419436.435
10:06 ET307676.425
10:08 ET853536.3702
10:10 ET136516.384
10:12 ET122226.355
10:14 ET488166.33
10:15 ET542806.31
10:17 ET271866.3142
10:19 ET499146.285
10:21 ET172776.2749
10:24 ET187726.286
10:26 ET125656.33
10:28 ET236226.295
10:30 ET174706.27
10:32 ET323796.265
10:33 ET392086.295
10:35 ET1134656.315
10:37 ET173446.32
10:39 ET140836.334
10:42 ET265926.2888
10:44 ET248696.31
10:46 ET205346.28
10:48 ET162046.275
10:50 ET123746.255
10:51 ET310296.245
10:53 ET477256.27
10:55 ET360376.24
10:57 ET243706.245
11:00 ET189056.245
11:02 ET170976.235
11:04 ET232616.224
11:06 ET227946.215
11:08 ET2129816.21
11:09 ET249386.195
11:11 ET312286.195
11:13 ET223586.19
11:15 ET396876.19
11:18 ET136756.18
11:20 ET269076.1589
11:22 ET1667386.1598
11:24 ET1161606.165
11:26 ET133496.155
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRXRX
Recursion Pharmaceuticals Inc
1.9B
-3.8x
---
United StatesNTLA
Intellia Therapeutics Inc
2.1B
-3.5x
---
United StatesARVN
Arvinas Inc
1.7B
-4.6x
---
United StatesSLNO
Soleno Therapeutics Inc
2.0B
-20.3x
---
United StatesBCYC
Bicycle Therapeutics PLC
1.6B
-5.8x
---
United StatesVRDN
Viridian Therapeutics Inc
1.7B
-5.4x
---
As of 2024-10-01

Company Information

Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate in silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881 and REC-3964. REC-994 is an orally bioavailable, superoxide scavenger small molecule being development for the treatment of symptomatic cerebral cavernous malformation (CCM). REC-2282 for the potential treatment of neurofibromatosis type 2. REC-3964 for the prevention of recurrent Clostridioides difficile infection.

Contact Information

Headquarters
41S Rio Grande StreetSALT LAKE CITY, UT, United States 84101
Phone
385-269-0203
Fax
801-581-7895

Executives

Independent Chairman of the Board
Robert Hershberg
President, Chief Operating Officer
Tina Larson
Chief Executive Officer, Director
Christopher Gibson
Chief Financial Officer
Michael Secora
Director, Chief Research and Development Officer, Chief Commercial Officer
Najat Khan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.9B
Revenue (TTM)
$49.6M
Shares Outstanding
282.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.80
EPS
$-1.63
Book Value
$1.98
P/E Ratio
-3.8x
Price/Sales (TTM)
37.5
Price/Cash Flow (TTM)
---
Operating Margin
-796.54%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.